Yu M#, Lei W#, Cao J#, Wang L#, Ma A, Zhao ZA, Yang HT, Shen Z, Lan F, Cao F, Liang P, Pei X, Xiang AP, Yu J, Zhang Y, Zhang Y, Li Q, Zhou J, Wei J, Peng Y, Zhu H, Liang L, Cao N, Fu B*, Hao J*, Zhao T*, Hu S*. Requirements for human cardiomyocytes. Cell Prolif. 2021 Oct 27;e13150. doi: 10.1111/cpr.13150. Online ahead of print.

Yu M, Han X, Ye L, Lei W, Hu S*. Generation of Human Induced Pluripotent Stem Cells from Renal Epithelial Cells. Methods Mol Biol. 2021 Oct 6. doi: 10.1007/7651_2021_419. Online ahead of print.

Han Z#, Xu Z#, Yu Y#, Cao Y, Bao Z, Gao X, Ye D, Yan G, Gong R, Xu J, Zhang L, Ma W, Wang X, Yang F, Lei H, Tian Y, Hu S, Bamba D, Li Y, Li D, Li C, Wang N, Zhang Y, Pan Z*, Yang B*, Cai B*. ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment. Mol Ther Nucleic Acids. 2021 May 29;26:22-33.

Yang J#, Ding N#, Zhao D#, Yu Y#, Shao C, Ni X, Zhao ZA, Li Z, Chen J, Ying Z, Yu M*, Lei W*, Hu S*. Intermittent Starvation Promotes Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes. Front Cell Dev Biol. 2021 Jul 30;9:687769.

Ye L#, Yu Y#, Wang Y, Huang Y, Yu M, Lei W, Tang JM*, Hu S*. Establishment and characterization of a human embryonic stem cell line carrying a heterozygous GATA4 T280M mutation. Stem Cell Res. 2021 May;53:102393.

Jiang X#, Chen Y#, Liu X#, Ye L, Yu M, Shen Z, Lei W*, Hu S*. Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells. Front Cell Dev Biol. 2021 May 17;9:672039.

Wang W#, Lei W#, Jiang L, Gao S, Hu S, Zhao ZG*, Niu CY*, Zhao ZA*. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment. J Transl Med. 2021 May 10;19(1):198.

Zhao D#, Lei W#, Hu S*. Cardiac organoid - a promising perspective of preclinical model. Stem Cell Res Ther. 2021 May 6;12(1):272.

Ye L#, Yu Y#, Zhao ZA#, Zhao D, Ni X, Wang Y, Fang X, Yu M, Wang Y, Tang JM, Chen Y, Shen Z, Lei W, Hu S*. Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect. Cardiovasc Res. 2021 May 6:cvab154. doi: 10.1093/cvr/cvab154.

Ni X, Yang Z, Ye L, Han X, Zhao D, Ding F, Ding N, Wu H, Yu M, Xu GY, Zhao ZA, Lei W, Hu S*. Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells. Acta Pharmacol Sin. 2021 Mar 8. doi: 10.1038/s41401-021-00621-8.

Wang Y#, Lei W#, Yang J#, Ni X, Ye L, Shen Z*,Hu S*. The updated view on induced pluripotent stem cells for cardiovascular precision medicine. Pflugers Arch. 2021 Feb 17. doi: 10.1007/s00424-021-02530-5

Huang Y#, Wu H#, Han X#, Wu J, Yu M, Zhao ZA, Shen Z, Hu S*, Lei W*. Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination. Stem Cell Res. 2021 Apr;52:102241.